Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
IPO
Common Stock
Private Placement
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Income) Loss Net of Income Taxes
IPO
Private Placement
Total
Balance at Dec. 31, 2019     $ 140         $ 283,457 $ 34,488 $ (67)     $ 318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                   (153)     (153)
Stock-based compensation expense               802         802
Common stock issued upon exercise of stock options               70         70
Common stock issued upon exercise of stock options (in shares)     32                    
Net (loss) income                 2,440       2,440
Balance at Mar. 31, 2020     $ 140         284,329 36,928 (220)     321,177
Balance (in shares) at Mar. 31, 2020     139,753                    
Balance at Dec. 31, 2019     $ 140         283,457 34,488 (67)     318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                         78
Net (loss) income                         6,518
Balance at Jun. 30, 2020     $ 140         285,520 41,006 11     326,677
Balance (in shares) at Jun. 30, 2020     139,811                    
Balance at Mar. 31, 2020     $ 140         284,329 36,928 (220)     321,177
Balance (in shares) at Mar. 31, 2020     139,753                    
Foreign currency translation adjustment                   231     231
Stock-based compensation expense               1,140         1,140
Common stock issued upon exercise of stock options               51         51
Common stock issued upon exercise of stock options (in shares)     58                    
Net (loss) income                 4,078       4,078
Balance at Jun. 30, 2020     $ 140         285,520 41,006 11     326,677
Balance (in shares) at Jun. 30, 2020     139,811                    
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                   (799)     (799)
Stock-based compensation expense               2,538         2,538
Common stock issued upon exercise of stock options               538         538
Common stock issued upon exercise of stock options (in shares)     180                    
Net (loss) income                 5,644       5,644
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                         $ (444)
Common stock issued upon exercise of stock options (in shares)                         1,078
Net (loss) income                         $ (6,924)
Balance at Jun. 30, 2021     $ 158         670,674 48,017 567     719,416
Balance (in shares) at Jun. 30, 2021     157,768                    
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Foreign currency translation adjustment                   355     355
Stock-based compensation expense               4,714         4,714
Common stock issued upon exercise of stock options     $ 2         2,907         2,909
Common stock issued upon exercise of stock options (in shares)     871                    
RSU vested (in shares)     217                    
Conversion of Series A preferred stock to common stock in connection with initial public offering     $ 5 $ (610) $ 260,686     (260,081)          
Conversion of Series A preferred stock to common stock (in shares)     5,190 (61,006) (15,146)                
Issuance of stock $ 10 $ 1       $ 269,380 $ 29,999       $ 269,390 $ 30,000  
Issuance of stock (in shares) 9,977 1,111                      
Net (loss) income                 (12,568)       (12,568)
Balance at Jun. 30, 2021     $ 158         $ 670,674 $ 48,017 $ 567     $ 719,416
Balance (in shares) at Jun. 30, 2021     157,768